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acid protects against radiation toxicity via
retaining acyl-CoA-binding protein
Hui-wen Xiao1, Ming Cui1* , Yuan Li1, Jia-li Dong1, Shu-qin Zhang1, Chang-chun Zhu1, Mian Jiang1, Tong Zhu1,
Bin Wang1, Hai-Chao Wang2 and Sai-jun Fan1*

Abstract
Background: We have proved fecal microbiota transplantation (FMT) is an efficacious remedy to mitigate acute
radiation syndrome (ARS); however, the mechanisms remain incompletely characterized. Here, we aimed to tease
apart the gut microbiota-produced metabolites, underpin the therapeutic effects of FMT to radiation injuries, and
elucidate the underlying molecular mechanisms.
Results: FMT elevated the level of microbial-derived indole 3-propionic acid (IPA) in fecal pellets from irradiated
mice. IPA replenishment via oral route attenuated hematopoietic system and gastrointestinal (GI) tract injuries
intertwined with radiation exposure without precipitating tumor growth in male and female mice. Specifically, IPAtreated mice represented a lower system inflammatory level, recuperative hematogenic organs, catabatic
myelosuppression, improved GI function, and epithelial integrity following irradiation. 16S rRNA gene sequencing
and subsequent analyses showed that irradiated mice harbored a disordered enteric bacterial pattern, which was
preserved after IPA administration. Notably, iTRAQ analysis presented that IPA replenishment retained radiationreprogrammed protein expression profile in the small intestine. Importantly, shRNA interference and hydrodynamicbased gene delivery assays further validated that pregnane X receptor (PXR)/acyl-CoA-binding protein (ACBP)
signaling played pivotal roles in IPA-favored radioprotection in vitro and in vivo.
Conclusions: These evidences highlight that IPA is a key intestinal microbiota metabolite corroborating the
therapeutic effects of FMT to radiation toxicity. Owing to the potential pitfalls of FMT, IPA might be employed as a
safe and effective succedaneum to fight against accidental or iatrogenic ionizing ARS in clinical settings. Our
findings also provide a novel insight into microbiome-based remedies toward radioactive diseases.
Keywords: Radiotherapy, Acute radiation syndrome, Gastrointestinal tract toxicity, Hematopoietic toxicity, Gut
microbiota, Gut microbiota metabolite, Indole 3-propionic acid, ACBP
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Background
Cancer is a leading cause of death throughout the world.
Despite considerable advances in understanding the molecular basis of abdominal and pelvic neoplasms, abdominal and pelvic cancers, such as colorectal cancer,
prostate cancer, and cervical cancer, remain the most
common form of cancer leading tumor-related mortality
globally [1–3]. As a common feasible therapy approach,
about 50–60% of cancer patients receive radiotherapy
during their treatment courses [4]. Radiotherapy represents the most effective therapeutic regimen for patients
with cancer and improves their survival. However, the
final outcome of this single treatment modality is still
uncertain, with a high risk of recurrence among patients
with unfavorable side effects [5]. After radiation exposure,
a complex array of clinical complications are accompanied, such as bone marrow toxicity (hematopoietic syndrome) and gastrointestinal toxicity (GI syndrome), which
are collectively known as acute radiation syndrome (ARS)
[6]. Even for healthy populations, unwanted radiological
or nuclear exposure remains a serious public health risk
[7]. Unfortunately, effective countermeasure agents to attenuate ARS in exposed individuals remain an unmet
medical need.
The ecosystem of mammalian GI tract emerges as
home to trillions of microbes, including bacteria, archaea, viruses, and fungi, which collectively termed as
gut microbiota [8].The major function of gut microbiota
is to aid in the harvest of nutrients and energy from our
varied diets [9]. Furthermore, it influences a range of
metabolic, developmental, and physiological processes
affecting host health through stimulating the development of hosts’ immune system [10–12], protecting
against pathogen invasion [13], and regulating brain development and behavior [14]. The mammalian GI tract
is an essential mutualism exists within the intestinal mucosa [15]. Accordingly, the gut microbiota exerts its effects by producing bioactive compounds [16]. These
microbiota-derived metabolites signal to distant organs
in the body, which enables the enteric bacteria to connect to the immune and hormone system [17], brain
(the gut-brain axis) [18], and host metabolism, as well as
other functions [19]. Indole 3-propionic acid (IPA) is an
enteric microbiome-derived deamination product of
tryptophan and performs intracellular signaling activity
[20]. However, whether gut microbiota metabolites, such
as IPA, play a part in alleviating ARS and the underlying
molecular mechanism are elusive.
Acyl-CoA-binding protein (ACBP)/diazepam-binding
inhibitor (DBI) (hereafter named ACBP) is a 10-kDa
intracellular protein expressing in all eukaryotic species
and mammalian tissues investigated [21]. ACBP is
expressed at relatively high levels in the epidermis, particularly in the suprabasal layers, which are highly active
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in lipid synthesis [22]. In vitro studies indicate that
ACBP induces steroidogenesis in isolated adrenal mitochondria, inhibits glucose induced insulin secretion from
the pancreas, induces medium-chain acyl-CoA ester synthesis, and affects cell growth [23, 24]. In addition, whole
body ACBP knock-out mice have impaired anxiolytic responses to diazepam [25]. Pregnane X receptor (PXR) is
a ligand-activated nuclear receptor sensing and responding to a spectrum of chemical or nutritional stimuli including circulating IPA [26]. However, whether IPA
modulates the expression of ACBP through PXR required to be documented.
In this study, we sought to investigate whether IPA, a
bacterial-mediated production from tryptophan, ameliorates ARS using mouse models. Our observations demonstrated that oral gavage of IPA protected against bone
marrow and GI toxicity intertwined with radiation exposure. Mechanistically, IPA administration preserved
the intestinal bacterial composition structure and
retained the protein profile disturbed by irradiation. Importantly, PXR/ACBP axis was essential to IPA exerted
radioprotective function. Collectively, our findings provide new insights into the function and the underlying
protective mechanism of microbiota metabolites in the
context of ARS in a preclinical setting.

Results
IPA replenishment protects against radiation-induced
mortality in vitro and in vivo

Previously, we reported fecal microbiota transplantation
(FMT) could protect against ARS [27]. On the basis of the
study, we tested intestinal microbial metabolites from
mouse fecal extracts. Notably, both total body and abdominal irradiation exposure lessened the content of IPA, while
FMT erased the alterations (Fig. 1a, b). In addition, the
untargeted metabolomics KEGG analysis also enriched into
the pathway of indole alkaloid biosynthesis (Additional file
1: Figure S1A, B). In the survey of IPA production by representative members of the intestinal microbiota, only Clostridium was found to produce IPA [28]. Thus, we
compared the frequency of Clostridium in mouse fecal extracts based on our previous study [29]. 16S rRNA sequencing analysis showed that total abdominal irradiation
exposure lessened the level of Clostridium, while GI toxicity
rehabilitation was enmeshed with elimination of the shifts
(Fig. 1c). Initially, we identified whether IPA replenishment
could protect against death from exposure to irradiation.
After exposure to 7.2 Gy total body irradiation (TBI), the
male animal survival rate was decreased by 60% in the control vehicle group, but it was decreased by 50% or 30% in irradiation male animals receiving 3.75 or 7.5 mg/ml
concentration of IPA (via oral route, Fig. 1d). Body weight
loss is considered as a treatment toxicity, and IPA administration also increased the body weight of irradiated mice
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Fig. 1 IPA replenishment protects against radiation-induced mortality in vitro and in vivo. a, b The concentrations of IPA in fecal pellets from
each cohort was measured at the end of receiving 10 days of FMT. The IPA levels are not significantly different between control vs TAI + FMT or
TBI + FMT. Significant differences between each two cohorts are indicated: *P < 0.05 and **P < 0.01; Student’s t test. c The relative abundance of
g_Clostridium was compared among control, TAI, and TAI + hydrogen-water groups through 16S rRNA sequencing analysis. d Kaplan-Meier
analysis of male mice treated with the indicated irradiation and with IPA or saline. n = 24 per group. *P < 0.05 by log-rank test between 7.5 mg/
ml IPA and TBI groups. e, f Body weights were compared among male mice after 7.2 Gy TBI or 12 Gy TAI, n = 24 per group; Significant
differences between each two cohorts are indicated: *P < 0.05, **P < 0.01, and ***P < 0.005; Student’s t test. g–i The effects of concentration
gradient IPA on the proliferation of MODE-K cells (g) and HIEC-6 cells (h–j) were assessed by CCK-8 assays and cloning formation assays,
respectively. Significant differences between each two cohorts are indicated: *P < 0.05, **P < 0.01, and ***P < 0.005; Student’s t test. k Body
weights were compared between FMT group and IPA group after 12 Gy TAI, n = 24 per group

after TBI or total abdominal irradiation (TAI) in a dosedependent fashion (Fig. 1e, f, and 7.5 mg/ml of IPA was
used as the optimal concentration in the following study),
indicating that IPA replenishment protects against
radiation-induced mortality and weight loss. In vitro, IPA
facilitated the proliferation of irradiated MODE-K and
HIEC-6 cells in a dose-dependent manner, as demonstrated
by cell counting kit-8 (CCK-8) assays (Fig. 1g, h and
Additional file 1: Figure S1C, D) and cloning formation
(Fig. 1i, j). Of note, the body weight of TAI-exposed mice
treated with FMT or IPA showed no significant difference,
indicating that IPA replenishment might mimic FMT to
mitigate radiation injuries (Fig. 1k). Thus, we conclude
that IPA administration protects against radiationinduced mortality in vitro and in vivo.
Oral gavage of IPA ameliorates TBI-associated
hematopoietic system injury

Given the hematopoietic system is especially sensitive to
total body irradiation representing as atrophic hematogenic

organs and a massive loss of hematopoietic stem cells in
mouse models, we addressed the protective effects of IPA
on hematopoietic system in male mice. Four gray of TBI reduced the volumes and weight of thymus and spleen, which
restored by IPA treatment (Fig. 2a–d). Peripheral blood
(PB) analysis revealed that the irradiated mice exhibited a
significant decrease in WBC counts, RBC counts, HGB,
percentage of neutrophil granulocytes (NE%), and lymphocytes (LY%); nevertheless, oral gavage of IPA attenuated the
decrease of those in peripheral blood (Fig. 2e, f and Additional file 1: Figure S2A-C). Inflammatory markers (IL-6
and TNFɑ) as well as oxidative stress marker (MDA) were
significantly elevated in PB from irradiated animals, which
were reduced following IPA treatment (Fig. 2g, h and Additional file 1: Figure S2D). Hematopoietic stem and progenitor cell (HSPCs) exhaustion has been proposed to be
primarily responsible for myelosuppression induced by TBI
[30]. To determine whether IPA ameliorates myelosuppression by inhibiting HSPC exhaustion, we analyzed the HSC
cells (Lin−Sca-l+c-kit+) and HPCs (Lin−Sca-l−c-kit+) in BM
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Fig. 2 Oral gavage of IPA ameliorates TBI-associated hematopoietic system injury. a, b Photographs (a) and weight (b) of dissected thymuses
from mice in the three groups, the thymuses were obtained at day 15 after 4 Gy TBI. Mean ± SEM. Significant differences between each two
cohorts are indicated: ***P < 0.005; Student’s t test, n = 12 per group. c, d Photographs (c) and weight (d) of the dissected spleens from mice in
the three groups, the spleens were obtained at day 15 after 4 Gy TBI. Significant differences between each two cohorts are indicated: **P < 0.01
and ***P < 0.005; Student’s t test, n = 12 per group. e, f White blood cell (WBC) counts (e) and percentage of lymphocytes (LY%) (f) in PB were
measured at day 15 after 4 Gy TBI. The data were presented as means ± SEM (n = 12 per group). Significant differences between each two
cohorts are indicated: *P < 0.05 and ***P < 0.005; Student’s t test. g, h The content of IL-6 (g) and MDA (h) in PB were examined. Mean ± SEM.
Significant differences between each two cohorts are indicated: **P < 0.01 and ***P < 0.005; Student’s t test, n = 6 for control group; n = 11 for
TBI group; n = 12 for TBI + IPA group. i–k Representative FACS plots of HSCs, HPCs. The percentage of hematopoietic progenitor cells (HPCs) and
HSC cells in lineage-negative cells were analyzed at day 15 after 4 Gy TBI. The data were presented as means ± SEM (n = 6 per group). Significant
differences between each two cohorts are indicated: **P < 0.01 and ***P < 0.005; Student’s t test

cells 15 days after 4 Gy TBI. As shown in Fig. 2i–k, IPA
treatment increased percentages of HSC cells and HPCs
compared to saline-treated mice which suggested that IPA
significantly increased the recovery of BM HPCs/HSC cells
after TBI. Together, our observations demonstrated that
IPA replenishment could ameliorate TBI-accompanied
hematopoietic system injury.
IPA administration improves GI tract toxicity after total
abdominal irradiation

The small intestine is also the major sites of injury during radiation therapy, representing as enteritis, loss of GI
tract structure, and barrier function in mouse models.
To examine the protective effects of IPA on radiationinduced GI injury, we compared the colon length and
histologically small intestines from irradiated male mice
with or without IPA administration. As expected, IPA
replenishment reversed shortening of colon, losing of

intestinal villi, and decreasing of goblet cells, which were
observed in radiation group (Fig. 3a–c). Radiationelevated inflammatory cytokines, such as IL-6 and TNFɑ,
were reduced in TAI-exposed mice following IPA administration, suggesting that IPA ameliorated radiationinduced enteric inflammation (Fig. 3d, e and Additional
file 1: Figure S3A, B). We further validated that the expression of Glut1 (Slc2a1), Pgk1, and multidrug resistance protein 1 (MDR1), which all participated in
epithelial integrity maintaining after toxic stimuli [31],
reached about twofold higher levels in the small intestine tissues from irradiated mice with IPA treatment
(Fig. 3f–h). In addition, IPA administration decreased
the radiation-heightened FITC-dextran level in PB (Fig.
3i), indicating that IPA improves GI tract barrier
function and epithelial integrity in irradiated animals.
Massive production of reactive oxygen species (ROS) is
a shared feature of radiation stimuli, as our results
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Fig. 3 IPA administration improves GI tract toxicity after total abdominal irradiation. a, b Photographs (a) and length (b) of dissected colon from
mice in the three groups, the colon tissues were obtained at day 21 after 12 Gy TAI. Mean ± SEM. Significant differences between each two
cohorts are indicated: *P < 0.05 and ***P < 0.005; Student’s t test, n = 12 per group. c The morphology of the small intestine was shown by H&E
(×100 magnification; scale bar: 100 μm) and PAS (×1000 magnification; scale bar: 50 μm) staining. The small intestine tissues were obtained at day
21 after 12 Gy TAI. The arrows point to the goblet cells. d, e The content of IL-6 (d) and TNFɑ (e) in the small intestine tissues were examined by
ELISA. Mean ± SEM. Significant differences between each two cohorts are indicated: *P < 0.05, **P < 0.01, and ***P < 0.005; Student’s t test, n = 6
for control group, n = 11 for TAI group, n = 12 for TAI + IPA group. f–h The expression levels of Glut1 (f), Pgk1 (g), and MDR1 (h) were examined
in the small intestine tissues by qRT-PCR. The small intestine tissues were obtained at day 21 after 12 Gy TAI. Mean ± SEM. Significant differences
between each two cohorts are indicated: *P < 0.05 and **P < 0.01; Student’s t test, n = 12 per group. i The FITC-dextran in PB was assessed at
day 21 after 12 Gy TAI. Mean ± SEM. Significant differences between each two cohorts are indicated: **P < 0.01 and ***P < 0.005; Student’s t test,
n = 12 per group. j The expression levels of Nrf2 was assessed in the small intestine tissue by qRT-PCR. The small intestine tissues were obtained
at day 21 after 12 Gy TAI. Mean ± SEM. Significant differences between each two cohorts are indicated: *P < 0.05; Student’s t test, n = 12 per
group. k The content of MDA in the small intestine tissues were examined. Mean ± SEM. Significant differences between each two cohorts are
indicated: ***P < 0.005; Student’s t test, n = 6 for control group, n = 11 for TAI group, n = 12 for TAI + IPA group

showed that oral gavage of IPA blunted the radiationheightened Nrf2 and MDA levels in the small intestine
tissues (Fig. 3j, k). Together, IPA replenishment ameliorates radiation-caused GI toxicity by enhancing intestinal
barrier function and epithelial integrity, hindering
radiation-induced inflammation, and reducing ROS
levels.
IPA protects against radiation toxicity in mouse models
without accelerating tumor growth

To further identify the radioprotection of IPA, female
mice were treated with IPA following TBI or TAI

challenge via oral route. In parallel with their male counterparts, IPA replenishment mitigated radiation-induced
hematopoietic and GI syndromes in female mice. In detail, IPA administration elevated survival rate and body
weight (Fig. 4a and Additional file 1: Figure S4A), restored the atrophic thymus and spleen (Fig. 4b, c and
Additional file 1: Figure S4B, C), and heightened WBC
counts and percentage of lymphocytes in PB after radiation exposure (Fig. 4d and Additional file 1: Figure
S4D). For GI toxicity, IPA treatment prolonged colon
length (Fig. 4e and Additional file 1: Figure S4E), recovered intestinal villi and goblet cells (Additional file 1:
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Fig. 4 IPA protects against radiation toxicity in mouse models without accelerating tumor growth. a Kaplan-Meier analysis of female mice in the
three groups after 7.2 Gy TBI, n = 30 per group. *P < 0.05 by log-rank test between IPA and TBI groups. b, c Photographs of dissected the
thymuses and spleens from female mice in the three groups, and the thymuses and spleens were obtained at day 15 after 4 Gy TBI. n = 12 per
group. d White blood cell (WBC) counts in PB from female mice were measured at 15 days after 4 Gy TBI. The data were presented as means ±
SEM (n = 12 per group). Significant differences between each two cohorts are indicated: ***P < 0.005; Student’s t test. e Photographs of dissected
colon from female mice in the three groups, and the colon tissues were obtained at day 21 after 12 Gy TAI. n = 12 per group. f–h The expression
levels of Pgk1 (f), IL-6 (g), and Nrf2 (h) were examined in the small intestine tissues by qRT-PCR. The small intestine tissues were obtained at day
21 after 12 Gy TAI. Mean ± SEM. Significant differences between each two cohorts are indicated: *P < 0.05, **P < 0.01, and ***P < 0.005; Student’s
t test, n = 12 per group. i, j The growth images of HCT-8 and ME-180 cells in nude mice administrated with IPA and local radiation. k, l The
growth curve of HCT-8 and ME-180 cells in nude mice administrated with IPA and local radiation. Data are expressed as mean ± SEM from 7
mice. Statistically significant differences between each two cohorts are indicated: ***P < 0.001; Student’s t test. m The expressions of Ki-67 were
examined by immunohistochemistry staining in HCT-8 and ME-180 tumor tissues from nude mice

Figure S4F), facilitated small intestinal integrity (Fig. 4f
and Additional file 1: Figure S4G), and hindered enteritis
(Fig. 4g and Additional file 1: Figure S4H) and ROS level
(Fig. 4h). Together, our observations demonstrate that
gut microbiota-derived IPA protects both sexes from
ARS.
To investigate whether IPA can be employed to improve prognosis of radiotherapy in clinical application,
we further examined whether IPA precipitated cancer
cell proliferation in vivo. Male (or female) BALB/c athymic nude mice were injected with HCT-8 (or ME-180)
cells subcutaneously and treated with IPA with or without local radiation. Intriguingly, IPA replenishment did
not increase the volume and weight of the tumors in
animals receiving exogenous cancer cells (Fig. 4i–l and
Additional file 1: Figure S4I, J). Immunohistochemical
staining further validated that IPA unaltered the

expression of Ki-67, a marker of proliferation, in tumor
tissues with or without radiation challenge (Fig. 4m),
indicating that IPA treatment do not accelerate tumor
growth.
IPA treatment changes irradiation-shaped intestinal
bacterial structure

Next, we aimed to elucidate the underlying mechanism
of radioprotection by IPA. Given gut microbiota configurations relate to ARS progression, we addressed the effects
of IPA on the alterations of intestinal bacterial structure
in TAI-exposed male mice. At day 6 after radiation exposure, the observed species number of enteric bacteria
among control, TAI-exposed, and TAI-exposed with IPA
replenishment mice was unchanged (Additional file 1: Figure S5A, B). However, an unweighted principle coordinate
analysis (PCoA), principal component analysis (PCA), and
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non-metric multidimensional scaling (NMDS) analysis
were conducted to visualize differences in bacterial taxa
composition among the three groups (Additional file 1:
Figure S5C-E). Statistically, unweighted unifrac analysis
but not weighted revealed that TAI drove a marked difference in gut microbiota composition, whereas IPA administration narrowed the alterations (Additional file 1: Figure
S5F, G), suggesting that IPA might preserve TAI-shifted
bacterial composition to perform radioprotection. In details, TAI treatment caused a lower relative abundance of
Lactobacillus at the genus level (Additional file 1: Figure
S5H, I) and a higher relative abundance of g_Bacteroides_
acidifaciens and Ruminoccoccus_gauvreauii at the species
level (Additional file 1: Figure S5J, K), whereas IPA administration reversed these changes. Linear discriminant analysis effect size (LEfSe) assays exhibited the increases in
Blautia (genus), Proteobacteria (phylum), and Parabacteroides (genus) and decreases in Bacteroides (genus), Enterobacterides (order), and Escherichia coli (species) which are
the main altered microbes following IPA administration in
irradiated mice (Additional file 1: Figure S5L, M).
At day 12 after TAI exposure, the observed species
numbers of intestinal bacteria showed no difference
among the three cohorts (Fig. 5a, b). Although unweighted
unifrac analysis described no changes of the gut microbiota composition statistically (Additional file 1: Figure
S6A), PCA, PCoA, and NMDS plot indicated an obvious
separation after IPA administration in irradiated mice
(Fig. 5c, d and Additional file 1: Figure S6B). Weighted
unifrac analysis revealed that TAI drove a marked difference in gut microbiota composition, whereas IPA administration reduced the alterations (Fig. 5e), suggesting that
IPA might preserve TAI-shaped bacterial composition to
perform radioprotection. In detail, however, TAI exposure
kept the relative abundance of Bacteroides (at the genus
level, Fig. 5f and Additional file 1: Figure S6C) and Rhodanobacter_thiooxydans (at the species level, Fig. 5g) at a
higher level; IPA replenishment retained that of Bacteroides and Rhodanobacter_thiooxydans (Fig. 5f, g and
Additional file 1: Figure S6C). LEfSe assays further indicated that the Enterobacteriales became more abundant
after radiation exposure compared to IPA group, in which
Blautia and Porphyromonadaceae were more abundant
(Fig. 5h and Additional file 1: Figure S6D). Collectively,
these results indicate that oral gavage of IPA changes
irradiation-disordered intestinal bacterial structure.
Since IPA impacted intestinal bacterial structure, we
are curious about whether IPA mitigates radiationinduced GI toxicity depending on enteric microflora.
Thus, the male mice were treated with antibiotics (ABX)
to clear gut microbes. As expected, ABX treatment lessened the content of IPA in fecal pellets, while IPA gavage abrogated the reduction (Fig. 5i). Importantly, IPA
replenishment failed to attenuate radiation-caused GI
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toxicity in ABX-challenged mice, manifested as shortening of colon (Fig. 5j, k), losing of intestinal villi (Fig. 5l,
first line) and decreasing of goblet cells (Fig. 5l, second
line). Furthermore, ABX treatment eradicated IPA replenishment rescued weight loss, enteric inflammation,
and ROS levels (Additional file 1: Figure S7), indicating
that IPA protects against radiation-induced GI injuries
partly based on gut microbes.
IPA replenishment reprograms small intestinal protein
expression profile following TAI challenge

To further explore the molecular mechanism of radioprotection by IPA, we interrogated the responses of irradiated hosts to IPA treatment. iTRAQ analysis was
performed to identify small intestinal proteomic changes
among control and TAI-exposed male mice with or
without IPA replenishment. The significant differentially
expressed proteins were detected through screening of
the reliable proteins with a P value less than 0.05 and
multiple changes greater than 1.2 or less than 0.83, from
which 183 significant differential proteins of control
contrast TAI and 62 significant differential proteins of
TAI contrast IPA showed differential accumulation in
these two comparisons. As shown in Fig. 6a, the differential protein expression patterns were illustrated
through the volcano plot. Moreover, we analysis all of
the differential proteins via gene ontology (GO) enrichment, which was classified into biological process, cellular component, and molecular function. The biological
process analysis for the differential proteins in small intestine of TAI-challenged mice compared with control
mice were shown in Additional file 1: Figure S8A, from
which the differential proteins of small intestine were
mainly attributed to organonitrogen compound metabolic process (14.8%), cellular amide metabolic process
(9.4%) and peptide metabolic process (9.4%), whereas
the differential proteins detected among IPA group compared to TAI group (Fig. 6b) were majoring in humoral
immune response (8.7%), glycerol ether metabolic
process (8.7%) and ether metabolic process (8.7%). Besides
that, intracellular organelle part and cytoskeleton were the
most representative terms in cellular component (Fig. 6c
and Additional file 1: Figure S8B). Regarding the molecular function, 23.4% and 13% of the detected different proteins were annotated displaying the structural molecule
activity or substrate-specific transporter activity in TAI
group (Additional file 1: Figure S8C) or IPA supplement
group (Fig. 6d), respectively. On the basis of proteomic
changes, we found that irradiation decreased the level of
acyl-CoA-bind protein (ACBP) from the small intestinal
tissues while IPA replenishment reversed the change
through iTRAQ proteomic method and quantitative realtime PCR in male and female mice (Fig. 6e, f and
Additional file 1: Figure S8D, E). In addition, ACBP was
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Fig. 5 IPA preserves irradiation-shifted enteric bacterial composition at day 12 after TAI. a, b The observed species number and Chao1 diversity
index of intestinal bacteria was examined by 16S rRNA high-throughput sequencing after 12 days of TAI exposure. Significant differences are
indicated: Wilcoxon rank sum test. n = 6 per group. c, d PCoA and NMDS were used to measure the shift in intestinal bacterial composition
profile after irradiation at day 12. e The β diversity of intestinal bacteria was compared by the weighted unifrac analysis. Significant differences are
indicated: Wilcoxon rank sum test. n = 6 per group. f The alteration of intestinal bacterial patterns at the genus level was assessed by 16S rRNA
sequencing, n = 6 per group. The heat map is color-based on row Z-scores. The mice with the highest and lowest bacterial level are in red and
blue, respectively. g The abundances of most varied strain bacteria was assessed using 16S high-throughput sequencing after irradiation at day
12. Statistically significant differences are indicated: Wilcoxon rank sum test, n = 6 per group. h Linear discriminant analysis (LDA) effect size
(LEfSe) results represented significantly different in abundance of gut bacteria between TAI and IPA groups and indicated the effect size of each
differentially abundant bacterial taxon in the small intestine after irradiation at day 12, n = 6 per group. Significant differences are indicated:
Wilcoxon rank sum test. i The content of IPA in fecal was examined by ELISA. Mean ± SEM. Significant differences between each two cohorts are
indicated: *P < 0.05 and ***P < 0.005; Student’s t test, n = 8 per group. j, k Photographs (j) and length (k) of dissected colon from IPA gavage
mice with or without antibiotics (ABX) treatment, the colon tissues were obtained at day 21 after 12 Gy TAI. Mean ± SEM. Significant differences
are indicated: Student’s t test, n = 6 per group. l The morphology of the small intestine was shown by H&E (× 100 magnification; scale bar:
100 μm) and PAS (× 1000 magnification; scale bar: 50 μm) staining. The small intestine tissues were obtained at day 21 after 12 Gy TAI. The arrows
point to the goblet cells

activated by IPA in 2 h with or without irradiation exposure in normal human intestinal epithelial cells (HIEC-6)
(Fig. 6g), implying that ACBP might be a rapid response
gene for rehabilitation drove by IPA.
Next, HIEC-6 and mouse intestinal epithelial cells
(MODE-K) were employed to further validate the role of
ACBP in IPA-mitigated radiation mortality. As shown in
Fig. 6h and Additional file 1: Figure S9A, IPA treatment
erased the reduction of ACBP following irradiation.
Using special siRNA targeting ACBP (Additional file 1:
Figure S9B), cloning formation and CCK-8 assays further
revealed that depletion of ACBP blocked the protective
function of IPA toward irradiation in HIEC-6 cells (Fig.

6i–k). IPA has been reported as a ligand for pregnane X
receptor (PXR) [32]. Bioinformatics analysis showed two
PXR binding sites located in the region of ACBP promoter
(http://alggen.lsi.upc.es/). Thus, two fragments carried the
binding sites were constructed into PGL3-basic plasmid
and named as PGL3-ACBP-1 and PGL3-ACBP-2 (Fig. 6l).
Luciferase reporter assays revealed that IPA activated the
ACBP promoter carrying PXR binding site region (position
668–678; Fig. 6m), rather than the other region (position
478–488; Additional file 1: Figure S9C). Notably, using special siRNA to silence PXR (Additional file 1: Figure S9D)
abrogated the activation of PGL3-ACBP-1 and the upregulation of ACBP drove by IPA in HIEC-6 cells (Fig. 6m, n).
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Fig. 6 IPA replenishment reprograms small intestinal protein expression profile following TAI challenge. a Volcano plots of identified different
proteins from the small intestine of mice with or without IPA treatment. In the volcano plots, each point represented a protein. b–d
Bioinformatics analysis of different proteins in small intestine of mice in IPA gavage group compared to the TAI group through gene ontology
(GO) in biological process (b), cellular component (c), and molecular function (d). Information on the number of involved proteins in a term is
shown on the x-axis. e Hierarchical cluster analysis for the different proteins in the small intestine of mice in IPA gavage group compared to TAI
group. f The expression level of ACBP was examined in small intestine tissues from male mice by qRT-PCR. Mean ± SEM. Significant between
each two cohort differences are indicated: *P < 0.05; Student’s t test, n = 18 per group. g The relative level of ACBP were measured at the time of
0, 0.5, 1, 1.5, and 2 h with (or without) 4 Gy irradiation after IPA treatment (37.8 μg/mL) by qRT-PCR. Mean ± SEM. Significant differences between
each two cohorts are indicated: ***P < 0.005; Student’s t test. h The mRNA levels of ACBP were examined in HIEC-6 and MODE-K cells which
included control, 4 Gy irradiation, and 4 Gy irradiation with IPA supplement. i–k The effects of IPA (37.8 μg/mL) on the proliferation of ACBP
siRNA-treated HIEC-6 cells were assessed by cloning formation (i, j) and CCK-8 assays (k), respectively. Mean ± SEM. Significant differences
between each two cohorts are indicated: *P < 0.05, **P < 0.01, and ***P < 0.005; Student’s t test. l A model showed the predicted binding site for
PXR at 678–668 nt and 488–478 nt of ACBP mRNA promoter named PGL3-ACBP-1 and PGL3-ACBP-2. m The effect of PXR and IPA on PGL3-ACBP1 reporter was measured by luciferase reporter gene assays in HIEC-6 cells. Mean ± SEM. Significant differences between each two cohorts are
indicated: **P < 0.01; Student’s t test. n The expression of ACBP was examined by qRT-PCR after transfection of HIEC-6 cells with si-PXR and (or)
treated with IPA (37.8 μg/mL)
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Together, our observations indicate that the protective
function of IPA against irradiation partly depends on
ACBP.
ACBP contributes to the radioprotection of IPA via PXR

Hydrodynamic-based gene delivery has emerged as an
efficient and simple method for the intracellular transfection of plasmid in vivo [33]. To silence the expression
of ACBP (or PXR), the specific shRNA targeting ACBP
(or PXR) was cloned in pRNA-U6.1/Neo plasmids and
rapidly injected into retro-orbital sinus of male mice to
inhibit the expression of ACBP (or PXR). Fluorescence
imaging validated the accumulation of the reconstructive
pRNA-U6.1/Neo plasmids in various dissected organs
including the liver, colon, small intestine, and tongue,
but not in the heart and kidney (Fig. 7a). qRT-PCR further revealed the downregulation of ACBP (or PXR) expression in the small intestine following the special
pRNA-U6.1/Neo plasmids injection (Fig. 7b, c), indicating that hydrodynamic-based retro-orbital sinus injection can serve as a means of introducing transgenes
specifically to the small intestine. Then, we identified
whether IPA replenishment accompanied with ACBP or
PXR knockdown could still protect against ARS. After
exposure to 12 Gy TAI, ACBP, or PXR silencing amplified the body weight loss (Fig. 7d). Besides that, the irradiated mice with ACBP or PXR deletion showed
deteriorative GI tract injuries characterized by shorter
colon length (Fig. 7e, f), higher inflammation and ROS
levels (Fig. 7g, h and Additional file 1: Figure S10A),
fewer intestinal villi and goblet cells (Fig. 7i), worsen the
epithelial integrity (Fig. 7j and Additional file 1: Figure
S10B, C), and GI tract barrier function (Fig. 7k), indicating that IPA performs radioprotection to GI tract partly
depending on PXR/ACBP signaling.

Discussion
Recent efforts to define the complex nature of diseases
have focused on the contribution of host microbiota.
Fecal microbiota transplantation (FMT) is historically
known to be a therapeutic intervention to treat GI and
non-GI diseases, covering CDI [34] and cancers [35]. Recently, we reported that FMT might be employed as a
therapeutic avenue to protect against ARS. In clinical
application, however, FMT has some limitations including aesthetic concerns, costs of donor screening, and
material preparation and administration [36, 37]. Hence,
search for effective treatment options through identifying the functional constituents in fecal pellets superseding FMT to prevent various diseases may have broader
implications. The components in fecal samples include
viable bacteria (~ 1011 per gram of wet stool), colonocytes (~ 107 per gram of wet stool), archaea (~ 108 per
gram of wet stool), viruses (~ 108 per gram of wet stool),
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fungi (~ 106 per gram of wet stool), protists, and metabolites [38]. Once established in the intestine, the microbiota influences host immune response [39] and
gastrointestinal barrier function [32] through metabolic
activities such as short-chain fatty acids from carbohydrate metabolism and tryptophan metabolites from
amino acid metabolism. In light of our previous study,
we focused on the alteration of gut microbiota metabolites, and obtained that radiation exposure lessened the
level of IPA in fecal pellets, which could be preserved by
FMT.
These microbial metabolites are generated through
microorganism-microorganism and host-microorganism
interactions, and there is a growing appreciation of a
role for this co-metabolism in human health and disease
[40, 41]. There is an emerging understanding the relationship between microbiota metabolism and host physiology, which includes host metabolism [42, 43], gut
immunity [44], cancer [45], asthma [46], and nervous
system [47]. Moreover, some studies exist that IPA, a
bacterial-mediated production of bioactive indolecontaining metabolites derived from tryptophan, is a ligand for PXR and promotes intestinal barrier integrity
through downregulation of epithelial TNFɑ, induction of
MDR1, and regulation of epithelial junctional complexes
[32]. The intestinal epithelial is one of the most rapidly
renewing system in animal, which makes the small intestine as the most sensitive and vulnerable part of GI tract
to irradiation [48]. Specifically, radiation stimuli impairs
enteric integrity and mediates intestinal barrier dysfunction [29]. Here, we observed that oral gavage of IPA enhanced the integrity and function of GI tract. Recently,
several studies have shown that microbiota-derived indole metabolites promote human and murine intestinal
homeostasis through mitigating inflammatory responses
like interleukin-10 receptor [20, 49]. In this study, radiation challenge elevated the levels of inflammatory mediators, such as IL-6 and TNFɑ, in PB, and intestine
tissues; however, IPA replenishment by oral route erased
the alterations. Thus, IPA restores radiation-induced intestinal flora dysbiosis might through regulating inflammatory responses which need further study. In addition,
it is well documented that IPA protects neurons from
ischemia-induced neuronal damage by reducing DNA
damage and lipid peroxidation [50]. Intriguingly, IPA replenishment restored the size and weight of the spleen
(and thymus) and raised a series of blood cell counts, indicating the rehabilitation of hematopoietic toxicity concomitant with total body irradiation. Together, irradiated
mice that received IPA not only exhibited fewer mortality and radiation induced physical signs, but also had significantly less damage to GI tract and hematopoietic
system. Importantly, IPA performed radioprotection to
both male and female experimental animals and did not
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Fig. 7 ACBP contributes to the protective function of IPA toward irradiation via PXR. a The presence of gene expression after injection in various
organs, including the liver, heart, lung, colon, small intestine, and tongue, as confirmed by bioluminescent imaging. b, c The expression level of
ACBP (b) and PXR (c) was examined in the small intestine tissues by qRT-PCR. Significant differences are indicated: *P < 0.05 and ***P < 0.005;
Mean ± SEM. Student’s t test, n = 10 per group. d Body weights were compared among four group mice after 12Gy TAI, n = 18 per group;
*P < 0.05, **P < 0.01, and ***P < 0.005 represent TAI + sh-ACBP group compared with TAI + IPA group; #P < 0.05, ##P < 0.01, and ###P < 0.005
represent TAI + sh-PXR group compared with TAI + IPA group; Student’s t test. e, f Photographs (e) and length (f) of dissected colon from mice
in the four groups, the colon tissues were obtained at day 21 after 12 Gy TAI. Mean ± SEM. Significant differences between each two cohorts are
indicated: *P < 0.05 and ***P < 0.005; Student’s t test, n = 5 for TAI group, n = 6 for TAI + IPA group, n = 10 for TAI + sh-ACBP group, n = 9 for
TAI + sh-PXR group. g, h, j The expression levels of IL-6 (g), Nrf2 (h), and Glut1 (j) were examined in the small intestine tissues by qRT-PCR. The
small intestine tissues were obtained at day 21 after 12 Gy TAI. Mean ± SEM. Significant differences between each two cohorts are indicated:
*P < 0.05, **P < 0.01, and ***P < 0.005; Student’s t test, n = 6 for control group, n = 6 for TAI group, n = 6 for TAI + IPA group, n = 10 for TAI + shACBP group, n = 9 for TAI + sh-PXR group. i The morphology of the small intestine was shown by H&E (×100 magnification; Scale bar: 100 μm) and
PAS (×1000 magnification; Scale bar: 50 μm) staining. The small intestine tissues were obtained at day 21 after 12 Gy TAI. The arrows point to the
goblet cells. k The FITC-dextran in PB was assessed at day 21 after 12 Gy TAI. Mean ± SEM. Significant differences between each two cohorts are
indicated: **P < 0.01 and ***P < 0.005; Student’s t test, n = 6 for control group, n = 6 for TAI group, n = 6 for TAI + IPA group, n = 10 for TAI + sh-ACBP
group, n = 9 for TAI + sh-PXR group
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precipitate cancer cell proliferation in tumor-bearing
mouse models. Given IPA is a metabolite of gut microbiota emerged in GI tract, our findings underpin that
IPA might be employed as a safe remedy to protect
against hematopoietic and GI toxicity intertwined with
radiation exposure in pre-clinical settings.
To date, except for bile acids, the effects of gut microbiota metabolites on the enteric bacteria remain poorly
defined [51]. In the previous study, we observed that
TAI exposure decreased the abundance of intestinal g_
Clostridium. However, IPA replenishment abolished the
shifts (data not shown). Given the relationship between
g_Clostridium and IPA production [28], we further
tested IPA content in feces pellets which appeared IPA
treatment increased TAI-induced lower content of IPA
(data not shown). Accordingly, we supposed that IPA
exerted its protective effects to irradiation partly
dependent on the enteric microbes. To address this hypothesis, mice were domesticated with antibiotics. As
expected, ABX-challenged mice failed to response to
IPA treatment, represented as serious GI tract toxicity
following TAI exposure. The findings suggest that gut
microbiome is indispensable parameters for the function
of microbiota metabolites. In addition, our observations
revealed that oral gavage of IPA changed irradiationshifted intestinal bacterial structure. Owing to the relationship between gut microbiota and hosts’ radiosensitivity [52], the protective function against irradiation of
IPA might partly dependent on the alterations of gut
microbiota. Gene expression profile is accounted for the
fate of cells [53, 54]. Thus, we further obtained that IPA
administration reprogrammed the protein expression
profile of small intestine tissues in irradiated mice. Specifically, our data supported that ACBP was an essential
regulator responding to radiation-caused GI injury.
ACBP has been shown to transport acyl-CoAs and donate them to various metabolic pathways [55], influence
directly glucose-induced insulin secretion, stimulation of
steroidogenesis, and modulation of cell proliferation
[22]. Further, a study shows that ACBP is required for
maintaining normal epidermal barrier function [56]. Patients with HIV infection reveal an inverse correlation of
serum IPA and LPS (marker of intestinal microbial
translocation), demonstrating that IPA regulates intestinal permeability in humans [57]. In the present study,
IPA treatment recovered radiation lessened ACBP via
orphan receptor PXR and showed beneficial effects on
intestinal epithelial barrier function, which consistent
with the notion that altered microbial metabolites correlates with intestinal homeostasis and intestinal barrier
function. In addition, we used hydrodynamic-based gene
delivery technique to block the expression of ACBP or
PXR, which lost the beneficial effects of IPA administration on intestinal homeostasis and intestinal barrier
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function. These findings furtherly proved that PXR/
ACBP signaling were essential to IPA exerted protective
effects. Activation of PXR inhibits tumorigenicity of
colon cancer cells [58], and PXR agonists may have potentials in inhibiting inflammation related diseases [59];
besides, we also identified that IPA did not precipitate
tumor growth in vivo, indicating that IPA might be
employed in clinical settings without potential pitfalls.
Thus, our work defines that indole metabolites IPA
could be employed as a supportive therapy in individuals
with ARS as well as provides important biology steps
toward a more comprehensive understanding of gut
microbiota and its metabolites.

Conclusions
In the present study, we identify gut microbiota metabolite indole-3-propionic acid (IPA) protects against
radiation-associated hematopoietic syndrome and GI
syndrome without accelerating tumor growth. Mechanistically, IPA retains enteric bacterial configurations and
small intestinal protein profile of radiation-challenged
hosts. In addition, IPA activates enteric PXR/ACBP signaling to perform protective function toward GI toxicity.
Clinically, IPA might be employed as a microbiomebased therapeutic approach toward radioactive disease,
and cancer patients might replenish IPA to alleviate clinical complications after radiotherapy. Importantly, ACBP
is a novel target for the development of radioprotective
drugs.
Methods
Mice

Six- to 8-week-old-male (around 20 g)/female (around
18 g) C57BL/6J mice and 4-week-old-male/female
BALB/c athymic nude mice were purchased from the
Beijing Huafukang Bioscience Co., Inc. (Beijing, China).
Mice were housed in the Specific Pathogen Free (SPF)
level animal facility at the Institute of Radiation Medicine (IRM), the Chinese Academy of Medical Sciences
(CAMS). Mice were kept under standard conditions
(ambient temperature 22 ± 2 °C, air humidity 40–70%
and a 12/12-h light/dark cycle) and continuous access to
a standard diet and water. Animal experiments were
performed according to the institutional guidelines
approved by the Animal Care and Ethics Committee of
IRM-PUMC, which complied with the Guide for the
Care and Use of Laboratory Animals and the National
Institutes of Health guide for the Care and Use of
Laboratory Animals.
Cell culture

HIEC-6, MODE-K, HCT-8, and ME-180 cells were obtained from the American Type Culture Collection
(ATCC) and certified to be mycoplasma-free. The
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passage numbers of those cell lines during the experimental period were no more than eight. The cells were
cultured with 10% fetal bovine serum (Gibco, Grand
Island, NY, USA), 100 U/ml penicillin and 100 mg/ml
streptomycin and grown at 5% CO2 and 37 °C.
Irradiation study

A Gammacell-40 137Cs irradiator (Atomic Energy of
Canada Limited, Chalk River, ON, Canada) at a dose
rate of 1.0 Gy per minute was used for all experiments.
Mice treated with total body irradiation (TBI) were exposed to 4 Gy (for hematopoietic system experiments) or
7.2 Gy (for survival rate experiments) γ-ray. Mice were
anesthetized with 3.5% chloral hydrate intraperitoneal injection (around 200 μL per mouse) and treated with total
abdominal irradiation (TAI) for GI tract experiments were
exposed to 12 Gy γ-ray using a lead shielding (Additional
file 1: Figure S11) so that the whole abdomen will be irradiated and the other parts of the mouse will be shielded.
Control mice were sham-irradiated.
Experimental group

(1) The control group is the following: healthy 6- to 8week-old-male or female C57BL/6 mice. (2) TBI group:
in survival rate test, mice were exposed to 7.2 Gy total
body irradiation, and in hematopoietic system experiments, mice were exposed to 4 Gy total body irradiation.
(3) TAI group: Mice were exposed to 12 Gy total of abdominal irradiation. (4) TBI + IPA group: Mice were
treated with IPA 7.5 mg/ml IPA through oral route, dissolved in sterile water in 0.2 ml volume per mice for 15
consecutive days after 4 Gy or 7.2 Gy TBI. (5) TAI + IPA
group: Mice were treated with IPA 7.5 mg/ml IPA
through oral route, dissolved in sterile water in 0.2 ml
volume per mice for 15 consecutive days after 12 Gy
TAI. (6) TAI + ABX + IPA group: Mice were treated for
20 days with antibiotics (ABX) in their drinking water
before irradiation. Then, mice were treated with IPA 7.5
mg/ml IPA through oral route and dissolved in sterile
water in 0.2 ml volume per mice for 15 consecutive days
after 12 Gy TAI. (7) TAI + sh-ACBP+IPA group: After
12 Gy TAI mice were immediately injected with shACBP plasmid solution, then treated with IPA 7.5 mg/
ml IPA through oral route, and dissolved in sterile water
in 0.2 ml volume per mice for 15 consecutive days. (8)
TAI + sh-PXR + IPA group: After 12 Gy TAI mice were
immediately injected with sh-PXR plasmid solution, then
treated with IPA 7.5 mg/ml IPA through oral route, and
dissolved in sterile water in 0.2 ml volume per mice for
15 consecutive days.
Quantification of IPA

Fecal microbiota transplantation was performed to mice
with total body or abdominal irradiation for 10 days.
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Then, the fecal pellets were collected under SPF conditions. The fecal pellets from each cohort was weighed
and diluted with 1 ml of saline per 0.1 g of stool. Briefly,
the stool was steeped in saline for about 15 mins, shaken
and then centrifuged at 800 rpm for 3 mins. The supernatant was obtained to assess the level of IPA using
ELISA kit according to the manufacturer's protocol (Zcibio, Shanghai, China). Optical density was read at 450
nm (Rayto, Shenzhen, China).
Antibiotics test

TAI + ABX and TAI + ABX + IPA mice were treated
for 20 days with Ciprofloxacin (125 mg/L, SigmaAldrich, Madrid, Spain), Metronidazole (100 mg/L,
Sigma-Aldrich, Madrid, Spain), Vancomycin (50 mg/L,
Sigma-Aldrich, Madrid, Spain), Streptomycin (100 U/L,
Solarbio, Beijing, China) and Penicillin (100 U/L, Solarbio, Beijing, China) in their drinking water before irradiation, respectively. The fresh antibiotic solution was
prepared every day to promise its activity.
Histology

Following euthanasia, the small intestines of mice were
fixed in 4% buffered formalin overnight at room
temperature and then embedded in paraffin. Tissues
were sectioned at 5 μm thickness and dipped in
hematoxylin and eosin (H&E) using standard protocols.
For PAS staining, the small intestines of mice were fixed
in Carnoy's solution. Dewaxed sections were hydrated
and incubated in 1% periodic acid for 10 min followed
by incubation in Schiff’s reagent for 10 min. Sections
were counterstained with Mayer’s hematoxylin for 30 s,
washed and dehydrated before mounting with Pertex.
For immune-histochemical staining (IHC), deparaffinized sections were rehydrated and stained using the
primary antibodies of mouse anti-Ki-67 (Cell Signaling
Technology, MA, USA, 1:400 dilution). Then horseradish peroxidase (HRP) - conjugated secondary antibody
(ZSGB-BIO, Beijing, China) was used. For HRPconjugated secondary antibody, stained by 3, 3′-diaminobenzidine Staining Kit (BD Biosciences), followed by
hematoxylin nuclear counterstaining.
Untargeted metabolomics—metabolite extraction

Feces were individually grounded with liquid nitrogen
and the homogenate was suspended with prechilled 80%
methanol and 0.1% formic acid by well vortexing. The
samples were incubated on ice for 5 min and then were
centrifuged at 15000 rpm, 4 °C for 5 min. A some of
supernatant was diluted to final concentration containing 60% methanol by LC-MS grade water. The samples
were subsequently transferred to a fresh Eppendorf tube
with 0.22 μm filter and then were centrifuged at 15000 g,
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4 °C for 10 min. Finally, the filtrate was injected into the
LC-MS/MS system analysis.
Untargeted metabolomics—UHPLC-MS/MS analysis

LC-MS/MS analyses were performed using a Vanquish
UHPLC system (Thermo Fisher) coupled with an Orbitrap Q Exactive HF-X mass spectrometer (Thermo
Fisher). Samples were injected onto an Hyperil Gold column (100 × 2.1 mm, 1.9 μm) using a 16-min linear gradient at a flow rate of 0.2 mL/min. The eluents for the
positive polarity mode were eluent A (0.1% FA in Water)
and eluent B (Methanol). The eluents for the negative
polarity mode were eluent A (5 mM ammonium acetate,
pH 9.0) and eluent B (Methanol). The solvent gradient
was set as follows: 2% B, 1.5 min; 2-100 % B, 12.0 min;
100 % B, 14.0 min; 100-2 % B, 14.1 min; 2 % B, 16 min.
Q Exactive HF-X mass spectrometer was operated in
positive/negative polarity mode with spray voltage of 3.2
kV, capillary temperature of 320 °C, sheath gas flow rate
of 35 arb and aux gas flow rate of 10 arb.
Untargeted metabolomics—data analysis

The raw data files generated by UHPLC-MS/MS were
processed using the Compound Discoverer 3.0 (CD 3.0,
Thermo Fisher) to perform peak alignment, peak picking, and quantitation for each metabolite. The main parameters were set as follows: retention time tolerance,
0.2 minutes; actual mass tolerance, 5 ppm; signal intensity tolerance, 30%; signal/noise ratio, 3; and minimum
intensity, 100000. After that, peak intensities were normalized to the total spectral intensity. The normalized
data was used to predict the molecular formula based on
additive ions, molecular ion peaks and fragment ions.
And then peaks were matched with the mzCloud
(https://www.mzcloud.org/) and ChemSpider (http://
www.chemspider.com/) database to obtain the accurate
qualitative and relative quantitative results.
Bacterial diversity analysis

Stool samples were freshly collected from two independent experiments and stored at -80 °C until use. DNA was
extracted from the stool using the Power Fecal® DNA
Isolation Kit (MoBio Carlsbad, CA USA). The DNA was
recovered with 30 ml of buffer in the kit. PCR products
were mixed in equidensity ratios. Then, mixture PCR
products were purified with Qiagen Gel Extraction Kit
(Qiagen, Germany). The 16S ribosomal RNA (rRNA) V4
was amplified used specific primer. All PCR reactions
were carried out with Phusion® High-Fidelity PCR Master Mix (New England Biolabs). Sequencing libraries
were generated usingTruSeq® DNA PCR-Free Sample
Preparation Kit (Illumina, USA) following manufacturer's recommendations and index codes were added. The
library quality was assessed on the Qubit@ 2.0
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Fluorometer (Thermo Scientific) and Agilent Bioanalyzer
2100 system. At last, the library was sequenced on an
IlluminaHiSeq2500 platform and 250 bp paired-end
reads were generated. Paired-end reads was assigned to
samples based on their unique barcode and truncated by
cutting off the barcode and primer sequence. Paired-end
reads were merged using FLASH (V1.2.7,http://ccb.jhu.
edu/software/FLASH/), a very fast and accurate analysis
tool, which was designed to merge paired-end reads
when at least some of the reads overlap the read generated from the opposite end of the same DNA fragment,
and the splicing sequences were called raw tags. Quality
filtering on the raw tags were performed under specific
filtering conditions to obtain the high-quality clean tags
according to the QIIME (V1.7.0, http://qiime.org/index.
html) quality-controlled process. The tags were compared with the reference database (Gold database, http://
drive5.com/uchime/uchime_download.html)
using
UCHIME algorithm (UCHIME Algorithm, http://www.
drive5.com/usearch/manual/uchime_algo.html) to detect
chimera sequences, and then the chimera sequences
were removed. Then the Effective Tags finally obtained.
(Novogene Bioinformatics Technology Co., Ltd.). Sequences analysis was performed by Uparse software
(Uparse v7.0.1001, http://drive5.com/uparse/). Sequences
with ≥97% similarity were assigned to the same OTUs.
Representative sequence for each OTU was screened for
further annotation. For each representative sequence,
the Silva123 Database was used based on RDP classifier
(Version 2.2, http://sourceforge.net/projects/rdpclassifier/) algorithmto annotate taxonomic information.
Briefly, each cohort contains 12 mice, and 6 mice share
one cage. For gut microbiota analysis, we collected 2
fecal pellets from one cage and 3 from the other cage to
avoid cage effects. Six C57BL/6 J mice without irradiation were grouped as Cond 6/12 at day 6/12. Six mice
with 12 Gy TAI at day 6/12 were grouped as TAI d 6/
12. For IPA performance, six mice have been treated
with IPA for 6/12 days, their stool samples were collected and grouped as TAI + IPA d 6/12. The primers
are listed in Supplementary Table 1.
Peptide fractionation and identification by MS/MS

In each group of mice, we randomly pooled tissue samples from 3, 3, and 4 mice to generate three protein extracts 1, 2, 3, respectively. The protein extraction
method was in accordance with the manufacturer’s
protocol. The tryptic peptides were labeled by the 8-plex
iTRAQ reagents (AB Sciex, FosterCity, CA) according to
the manufacturer’s protocol. After 2 h labeling reactions,
the labeled peptides were pooled together for further
peptide fractionation and identification. Each pool of
mixed peptides was lyophilized and dissolved in solution
A (25% ACN and 10 mM KH2PO4, pH = 3). Then, they
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were loaded onto an RP column (Luna C18, 4.6 × 150
mm, Phenomenex, CA) and eluted by a step linear elution program: 0-10 min equilibrated in 100 % solution A,
10-15 min fast elution from 0 to 12% of solution B (25%
ACN, 2 M KCL, 10 mM KH2PO4, pH = 3), 15-45 min
linear elution from 12 to 56% of solution B, and 45-57
min washing elution from 56 to 100 % of solution B.
The RP HPLC procedures were manipulated in an LC
solution 20A (Shimadzu, Nakagyo-ku, Kyoto, Japan) with
a flow rate of 0.5 mL/min, and the peptides were monitored at 214 nm. The fractionated peptides were collected at one tube/min during the linear elution period
and further pooled into the indicated fractions (10 for
exosome, 15 for exosome-free, and 18 for cells). Each
fraction was analyzed by a Q-Exactive mass spectrometer (Thermo Fisher Scientific) coupled with an EasynLC 1000 UPLC (Thermo Fisher Scientific) system
twice. Peptides were loaded on a precolumn (10 μm-C18
resin, 75 μm × 8 cm) and separated with an analytical
column (3-μm C18 resin, 75 μm × 11 cm, YMC Co.,
Ltd.) using acetonitrile gradients from 5 to 40% in 65
min at a flow rate of 400 nL/min. Spectra were acquired
in data-dependent mode. The 10 most intense ions of
+2, +3, and + 4 charge from each full scan (R = 70000)
were isolated for HCD MS2 (R = 17500) at 27% normalized collision energy (NCE) with a dynamic exclusion
time of 150 s.
Database searches for peptide, protein identification, and
quantitative data analysis

The raw MS/MS data were converted to MGF format by
Proteome Discoverer 1.3 (Thermo Fisher Scientific, Waltham, MA), and the exported MGF files were searched
by Mascot 2.3 (Matrix Science, Boston, MA) against the
database Uniprot (selected for Mus., unknown version,
16700 entries). An automatic decoy database search was
performed. Several parameters in Mascot were set for
peptide searching, including iTRAQ 8-plex for quantification, tolerance of one missed cleavage of trypsin,
methylthio for cysteine as a fixed modification, and oxidation for methionine as a variable modification. The
precursor mass tolerance was 15 ppm, and the product
ion tolerance was 0.8 Da. After database searching, the
DAT files were imported into Scaffold v4.3.2 (Proteome
Software Inc., Portland, OR). Scaffold was used to
organize all data, quantitate proteins, and validate peptide identification using the Peptide Prophet algorithm,
and unique proteins with at least two unique peptides
with a false discovery rate (FDR) < 0.01 were qualified
for further quantification analysis. The fold changes in
protein abundance were defined as the median ratio of
all significantly matched spectra with tag signals. For
iBAQ intensity analysis through Maxquant software
(version 1.5.0), proteins identified by at least 2 unique
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peptides were used. Heat maps of function categories
and abundance changes of the differential proteins were
generated by R software.
In vivo tumor xenograft assay

Four-week-old-male and female BALB/c athymic nude
mice were housed and treated according to the guidelines established by the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
Briefly, HCT-8 (or ME-180) cells were harvested and
suspended at 2 × 107 cells per mL in sterile PBS. Groups
of 4-week-old-male (injected with HCT-8 cells) and female (injected with ME-180 cells) nude mice were subcutaneously injected at the shoulder with 0.2 mL of the
cell suspensions. Once the tumors reached an average
volume of 100 mm3, the mice were randomly divided
into four groups (n = 7 per group) and respective treatments were given. Group I (vehicle control): saline as
control; Group II: IPA; Group III: local irradiation;
Group IV: IPA + local irradiation. IPA (7.5 mg/ml) was
given to tumor-bearing mice by oral gavage before each
dose of irradiation. Fractionated irradiation treatment (3
Gy per day) was given for days, till a cumulative dose of
12 Gy was achieved. For the radiation, mice were positioned under a lead shield (Additional file 1: Figure S11)
so that only the tumor area was exposed. Tumor sizes
were monitored twice weekly using digital caliper.
Tumor volume (V) was monitored by measuring the
length (L) and width (W) of the tumors and was calculated using the formula (L × W2) × 0.5. After 25 days,
tumor-bearing mice were sacrificed.
Statistical analysis

Each experiment was repeated at least three times. Data
were assessed normal distribution using the Kolmogorov–Smirnov test. The data are presented as the means
± SEM with respect to the number of samples (n) in
each group. Significance was assessed by comparing the
mean values using Student’s t test and Wilcoxon rank
sum test for independent groups as follows: *P < 0.05;
**P < 0.01; ***P < 0.005. Kaplan-Meier analysis was performed for survival analysis, and significance between
survival curves was determined by a log rank test.
Results with P < 0.05 were considered statistically significant. Experiments through the study have been performed
at least three times.
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